Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03685344
Title Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma


Durvalumab + Loncastuximab tesirine-lpyl

Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.